semaglutide tablets novo nordisk wins EU approval for Wegovy weight-loss pill Novo Nordisk and D Young

CrossRef High-fat diet, gut dysbiosis, and oxidative stress: A synergistic triangle in metabolic dysfunction-associated steatotic liver disease pathogenesis Zi-Rui Zhang, Ling She, Yi-Rong Cao, Yuan-Wen Chen World Journal of Hepatology .2026;[Epub] CrossRef Fibulin-3 as a reliable biomarker of fibrosis in obese subjects with metabolic dysfunction-associated steatotic liver disease Allen Anthony Larao, Silvia Palmisano, Deborah Bonazza, Discipio Marina, Marica Meroni, Anna Ludovica Fracanzani, Lory S Croc, Claudio Tiribelli, Paola Dongiovanni, Natalia Rosso, Pablo Giraudi Annals of Hepatology .2026

doi:10.1037/1064-1297.15.5.427

Canonico, M., Oger, E., Plu-Bureau, G., Conard, J., Meyer, G., Lvesque, H., Trillot, N., Barrellier, M

While heart palpitations specifically are not listed among the common adverse reactions in the FDA prescribing information for semaglutide products, increased heart rate is a documented effect, particularly with Wegovy

How It Works: Trim is an all natural way to lose weight and to maintain a healthy body weight